BioKier is a startup based in the United States.
BioKier is a clinical-stage company developing oral treatments designed to manage blood glucose and lipids by mimicking the effects of bariatric-metabolic surgery to improve health outcomes in diabetes patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.